We used The Human Protein Atlas (HPA) website to analyze the immunohistochemistry of SRD5A3 in tumor and normal tissues and found that the expression of SRD5A3 was higher in lymphoma, pancreatic cancer, and testicular cancer than in normal tissues (Fig 2B). Here, SRD5A3 is linked to neoplasm.